Overview
Announcements

Ordinary Index Rebalancing in the Solactive Pharma Breakthrough Value Index | March 2020

In the ordinary rebalance the following composition will be implemented:

ABBVIE INC
ALEXION PHARMACEUTICALS INC
BASILEA PHARMACEUTICA LTD.
BEIGENE LTD-ADR
BIOGEN INC
BIOMARIN PHARMACEUTICAL INC
BRISTOL-MYERS SQUIBB CO
CSL LTD ORD
EISAI
EMERGENT BIOSOLUTIONS INC
ENDO INTERNATIONAL PLC
GRIFOLS SA CLASS A
HALOZYME THERAPEUTICS INC
HORIZON THERAPEUTICS PLC
INCYTE CORP
IONIS PHARMACEUTICALS INC
IPSEN SA
JAZZ PHARMACEUTICALS PLC
KYOWA KIRIN CO LTD
MALLINCKRODT PLC
MESOBLAST LTD ORD
MOCHIDA PHARMACEUTICAL CO LTD ORD
NEKTAR THERAPEUTICS
NIPPON SHINYAKU CO LTD
NOVARTIS AG
PTC THERAPEUTICS INC
ROCHE HOLDING AG
SANOFI SA
SAREPTA THERAPEUTICS INC
SWEDISH ORPHAN BIOVITRUM AB
TAKEDA PHARMACEUTICAL
TORII PHARMACEUTICAL CO LTD
ULTRAGENYX PHARMACEUTICAL INC
UNITED THERAPEUTICS CORP
VERTEX PHARMACEUTICALS INC